Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.
Front Oncol
; 11: 661128, 2021.
Article
de En
| MEDLINE
| ID: mdl-33747972
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Type d'étude:
Risk_factors_studies
Langue:
En
Journal:
Front Oncol
Année:
2021
Type de document:
Article
Pays d'affiliation:
Chine
Pays de publication:
Suisse